197 related articles for article (PubMed ID: 35484649)
1. Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
Rambaldi B; Kim HT; Arihara Y; Asano T; Reynolds C; Manter M; Halpern M; Weber A; Koreth J; Cutler C; Gooptu M; Nikiforow S; Ho VT; Antin JH; Romee R; Ampudia J; Ng C; Connelly S; Soiffer RJ; Ritz J
Haematologica; 2022 Nov; 107(11):2617-2629. PubMed ID: 35484649
[TBL] [Abstract][Full Text] [Related]
2. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
[TBL] [Abstract][Full Text] [Related]
3. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
Nair P; Melarkode R; Rajkumar D; Montero E
Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
[TBL] [Abstract][Full Text] [Related]
4. T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
Bughani U; Saha A; Kuriakose A; Nair R; Sadashivarao RB; Venkataraman R; Patel S; Deshchougule AT; S SK; Montero E; Pai HV; Palanivelu DV; Melarkode R; Nair P
PLoS One; 2017; 12(7):e0180088. PubMed ID: 28672038
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic activated leukocyte cell adhesion molecule induces CD6
Qian Q; Cui N; Huang B; Zhao Y; Liu Q; Hu M; Li B; Wang Q; Miao Q; You Z; Ma X; Tang R
Front Immunol; 2022; 13():967944. PubMed ID: 36159854
[TBL] [Abstract][Full Text] [Related]
6. Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
Le Dantec C; Alonso R; Fali T; Montero E; Devauchelle V; Saraux A; Pers JO; Renaudineau Y
Immunol Res; 2013 Jul; 56(2-3):341-7. PubMed ID: 23576060
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
8. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
[TBL] [Abstract][Full Text] [Related]
9. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
[TBL] [Abstract][Full Text] [Related]
10. The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
Chalmers SA; Ayilam Ramachandran R; Garcia SJ; Der E; Herlitz L; Ampudia J; Chu D; Jordan N; Zhang T; Parodis I; Gunnarsson I; Ding H; Shen N; Petri M; Mok CC; Saxena R; Polu KR; Connelly S; Ng CT; Mohan C; Putterman C
J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981775
[TBL] [Abstract][Full Text] [Related]
11. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
[TBL] [Abstract][Full Text] [Related]
13. Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6.
Te Riet J; Helenius J; Strohmeyer N; Cambi A; Figdor CG; Müller DJ
J Cell Sci; 2014 Apr; 127(Pt 7):1595-606. PubMed ID: 24496453
[TBL] [Abstract][Full Text] [Related]
14. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
15. Modulation of CD6 function through interaction with Galectin-1 and -3.
Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
[TBL] [Abstract][Full Text] [Related]
16. Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy.
Kim YS; Kim MN; Lee KE; Hong JY; Oh MS; Kim SY; Kim KW; Sohn MH
Clin Exp Immunol; 2018 May; 192(2):151-164. PubMed ID: 29363753
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.
Hernández P; Moreno E; Aira LE; Rodríguez PC
Curr Drug Targets; 2016; 17(6):666-77. PubMed ID: 26844560
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
[TBL] [Abstract][Full Text] [Related]
19. Multifaceted effects of soluble human CD6 in experimental cancer models.
Simões IT; Aranda F; Casadó-Llombart S; Velasco-de Andrés M; Català C; Álvarez P; Consuegra-Fernández M; Orta-Mascaró M; Merino R; Merino J; Alberola-Ila J; González-Aseguinolaza G; Carreras E; Martínez V; Lozano F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217757
[TBL] [Abstract][Full Text] [Related]
20. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
